Renowned technology entrepreneur Dr. Ken Bajaj establishes secure, scalable, end-to-end enterprise AI solutions provider Dr. Ken Bajaj, CEO of DigitalNet.ai   “We envision a future where AI augments human potential as a true collaborator. Our mission is to make AI-powered business transformation faster, more effective and accessible for all commercial and government organizations, no matter where they are in their AI journey. By uniting the strengths of Harmonic AI, Zillion and Axis, DigitalNet.ai brings together the full range of expertise necessary to design, implement and scale AI across vertical markets, including healthcare, financial services, insurance, energy and government.” BETHESDA, Md.

First-of-its-kind platform brings residential and commercial under one roof, giving UK agents more control, higher earning potential, and global reach eXp Realty Launches UK Commercial Division, Expanding Agent Model Into $10B Market First-of-its-kind platform brings residential and commercial under one roof, giving UK agents more control, higher earning potential, and global reach BELLINGHAM, Wash., Oct. 08, 2025 (GLOBE NEWSWIRE) — eXp Realty®, the largest independent real estate brokerage in the world and a core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), has announced the launch of eXp UK Commercial, expanding the company’s commercial real estate capabilities in one of

Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) — Nilo Therapeutics, a biotechnology company harnessing neural circuits to restore immune homeostasis in disease, launched today with a $101 million Series A financing led by The Column Group (TCG), DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments. Coinciding with its launch, Nilo announced the appointment of Kim Seth, Ph.D., as Chief Executive Officer and Board director. Founded by world-leading scientists Charles Zuker, Ph.D.